CTOs on the Move

Anixa Biosciences

www.anixa.com

 
Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.anixa.com
  • 3150 Almaden Expressway
    San Jose, CA USA 95118
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Anixa Biosciences raised $10M on 03/22/2021

Similar Companies

Applied Proteomics

Applied Proteomics Inc. is advancing the application of proteomics to the development of diagnostics, companion diagnostics, and personalized medicine applications to power better medical decisions and care. API has developed a proteomics platform solution to make protein-based biomarker discovery possible as a replicable, industrial application ready to be applied to health diagnostic problems.

Nurse On Call

Nurse On Call is a Naples, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InnovaPrep

InnovaPrep is engaged in product development, manufacturing, sales, service, and related out-licensing of a collection of novel technologies enabling rapid detection of biological particles and pathogens. Our core business is biological sample collection, concentration and preparation. The company has commercialized a collection of market-disruptive platform technologies for rapid, automated concentration of biological particles. InnovaPrep`s 35 pending and awarded patents apply to highly efficient collection, recovery, and concentration of biological particles from air, surfaces, and liquids. Our elution process underlies many of these patents and enables recovery of particles from filters, membranes, surfaces, and objects. The primary utility for these technologies is to greatly improve the way biological samples, especially those containing pathogenic organisms, are collected and prepared for analysis beyond the state-of-the-art. These technologies fill a critical void that currently severely limits application of the most advanced biological detection systems to the billions of microbiological tests performed annually. Markets served: Biodefense, food safety, water safety, biopharma, clinical research, animal health, environmental monitoring and others.

OpGen

OpGen, Inc. is a leading innovator in rapid, accurate genomic and DNA analysis systems and services.